VOR (Vor Biopharma) Buyback Yield %: -7.01 (As of Jul. 11, 2026)


VOR Vor Biopharma Inc VOR
32 GF Score
Price $19.14
! 3 Warning Signs
View Full Analysis

What is Vor Biopharma Buyback Yield %?

Vor Biopharma VOR -3.09% 32 Buyback Yield % is -7.01 as of Jul. 11, 2026. GuruFocus rates VOR with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 742 Biotechnology companies, Vor Biopharma ranks better than 55.12% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Vor Biopharma's current buyback yield was -7.01%.

Vor Biopharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Vor Biopharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vor Biopharma Buyback Yield % Chart

Vor Biopharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial -43.79 -26.42 -3.00 -40.31 -64.80

Vor Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -62.00 -27.34 -12.63 -64.80 -7.76

VOR vs ODTX, ANNX, ABUS: Buyback Yield % Comparison

For the Biotechnology subindustry, Vor Biopharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vor Biopharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vor Biopharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Vor Biopharma's Buyback Yield % falls into.


VOR
32GF Score
Vor Biopharma Inc VOR
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vor Biopharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Vor Biopharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 328.206) / 506.4576
=-64.80%

Vor Biopharma's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 74.999) / 966.67824
=-7.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -7.01 mean?
Vor Biopharma (VOR) has a Buyback Yield % of -7.01 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Vor Biopharma and its competitors. According to the industry distribution chart, Vor Biopharma ranks #333 out of 742 companies in the Biotechnology industry, placing it in the top 44.9%.
Is Vor Biopharma's Buyback Yield % too high?
Vor Biopharma's current Buyback Yield % is -7.01. Based on the distribution chart, Vor Biopharma ranks #333 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Vor Biopharma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Vor Biopharma's Buyback Yield % compare to ODTX and ANNX?
According to the Biotechnology industry distribution chart, Vor Biopharma ranks #333 out of 742 companies for Buyback Yield %. This puts Vor Biopharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Vor Biopharma and its competitors. Vor Biopharma's current Buyback Yield % is -7.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vor Biopharma stock overvalued right now?
Vor Biopharma (VOR) has a current Buyback Yield % of -7.01. The current Buyback Yield % is -7.01. Vor Biopharma's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Vor Biopharma (VOR), the current Buyback Yield % is -7.01 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vor Biopharma Business Description

Address 500 Boylston Street, Suite 1350, Boston, MA, USA, 02116
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
32GF Score

Get the complete analysis for VOR

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.14
Price